Some Uncertainty Ahead For Towa Following Strong Financial Year
NHI Impact And Sunsho Acquisition Both Present Potential Risks
Executive Summary
Towa performed well during the financial year ended 31 March, delivering a ¥15.9bn profit, but questions remain about the impact of Japan’s NHI drug price revision and its acquisition of Sunsho Pharmaceuticals going forward.